---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-044817"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T12:59:58.434156+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Neuronetics Q4 rev $22.5M (+11% YoY); closes Greenbrook TMS, guides FY25 rev $145-155M

## Summary
- Q4 2024 total revenue $22.5M (+11% YoY); U.S. treatment session revenue $12.9M; clinic revenue from Greenbrook $4.4M.
- Net loss Q4 $(12.2)M or $(0.33) per share vs $(5.4)M or $(0.19) in Q4 2023.
- Acquired Greenbrook TMS on Dec 9, 2024 adding 95 U.S. clinics; secured $10M from Perceptive Advisors at close.
- Realized over $21M of $22M targeted annualized cost synergies from Greenbrook integration.
- Completed $18.9M secondary offering in Feb 2025; guides FY25 rev $145-155M and Q3 2025 cash flow positive.

## SEC filing metadata
- accession: 0001193125-25-044817
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312525044817/0001193125-25-044817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312525044817/d894924d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-044817
- JSON: https://secwatch.observer/filing/0001193125-25-044817.json
- Plain text: https://secwatch.observer/filing/0001193125-25-044817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.